Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis
Annals of Rheumatic Diseases,  Clinical Article

Papadopoulou A et al. – Mesenchymal stem cells (MSC) lose their immunomodulatory properties when infused in the inflammatory micromilieu of autoimmune arthritis. Conditioning of the recipient with bortezomib alters the disease microenvironment enabling MSC to modulate arthritis. Should milieu limitations also operate in human disease, this approach could serve as a strategy to treat rheumatoid arthritis (RA) by MSC.

Methods
  • MSC were tested both in an induced (adjuvant–induced) and a spontaneous (K/BxN) arthritis model. Arthritis was assessed clinically and histologically.
  • The proliferation of splenocytes and fibroblast–like synoviocytes (FLS) in the presence of MSC was measured by radioactivity incorporation.
  • Toll–like receptor (TLR) expression was measured by real–time PCR. T–regulatory cell (Treg) frequency, T–cell apoptosis and cytokine secretion were monitored by flow cytometry.

Results
  • MSC, in vitro, strongly inhibited critical cell populations; splenocytes and FLS.
  • In contrast, MSC proved ineffective in vivo, unless they were administered before disease onset, an effect implying that the inflammatory arthritic milieu potentially abrogates MSC immunomodulatory properties.
  • In order to alleviate inflammation before MSC infusion, the authors administered, at arthritis onset, a short course with a proteasome inhibitor, bortezomib, whereas MSC were infused when established disease was expected.
  • The bortezomib plus MSC group demonstrated a significantly decreased arthritis score over arthritic, MSC–only, bortezomib–only groups, also confirmed by histology and immunohistochemistry.
  • The bortezomib plus MSC combination restored TLR expression and Treg frequency in blood and normalised FLS and splenocyte proliferation, apoptosis and cytokine secretion.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

1 Sweetened carbonated beverage consumption and cancer risk: Meta-analysis and review European Journal of Cancer Prevention, August 1, 2014    Evidence Based Medicine    Review Article

2 A randomized trial of epidural glucocorticoid injections for spinal stenosis New England Journal of Medicine, July 7, 2014    Evidence Based Medicine    Clinical Article

3 Triglycerides and cardiovascular disease The Lancet, August 19, 2014    Evidence Based Medicine    Clinical Article

4 Atrial fibrillation and incident myocardial infarction JAMA, September 16, 2014    Evidence Based Medicine    Clinical Article

5 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

6 Morning blood pressure surge is associated with serum gamma-glutamyltransferase activity in essential hypertensive patients Journal of Human Hypertension, August 29, 2014    Clinical Article

7 Serum gamma-glutamyltransferase levels predict the progression of coronary artery calcification in adults with type 2 diabetes mellitus Angiology, September 3, 2014    Evidence Based Medicine    Clinical Article

8 Follow-up of blood-pressure lowering and glucose control in type 2 diabetes New England Journal of Medicine, September 23, 2014    Evidence Based Medicine    Clinical Article

9 Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis BMJ, August 20, 2014    Evidence Based Medicine    Clinical Article

10 A very low carbohydrate, low saturated fat diet for type 2 diabetes management: a randomized trial Diabetes Care, July 31, 2014    Clinical Article

11 Ivabradine in stable coronary artery disease without clinical heart failure New England Journal of Medicine, September 2, 2014    Evidence Based Medicine    Clinical Article

12 Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis The Lancet, September 15, 2014    Evidence Based Medicine    Clinical Article

13 Ultrasonography versus computed tomography for suspected nephrolithiasis New England Journal of Medicine, September 19, 2014    Evidence Based Medicine    Clinical Article
Exclusive Author Commentary

14 Perioperative atrial fibrillation and the long-term risk of ischemic stroke JAMA, August 26, 2014    Evidence Based Medicine    Clinical Article

15 High risk of failing eradication of Helicobacter pylori in patients with diabetes: A meta-analysis Diabetes Research and Clinical Practice, August 18, 2014    Review Article

16 Management of persistent pain in the older patient: A clinical review JAMA, September 10, 2014    Clinical Article

17 Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial The Lancet, August 5, 2014    Evidence Based Medicine    Clinical Article

18 Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial Annals of Internal Medicine, September 25, 2014    Evidence Based Medicine    Clinical Article

19 Relationship between tea consumption and pancreatic cancer risk: A meta-analysis based on prospective cohort studies and case-control studies European Journal of Cancer Prevention, August 1, 2014    Evidence Based Medicine    Clinical Article

20 Ebola virus disease in West Africa -- the first 9 months of the epidemic and forward projections New England Journal of Medicine, September 24, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close